semaglutide and tirzepatide. Semaglutide/Tirzepatide: Beyond Weight Loss: Shamsah Amersi, MD: OB-GYNs Comparative safety and side effects

The trial participants were at very high risk for subsequent cardiovascular events with 68% having had a heart attack (82% had coronary artery disease) and the rest with prior stroke or peripheral arterial disease or a combination of these entry criteria

I spoke with one of their clinicians during my research phase

For patients ordering across both age windows, comparing a delivery option against home cooking or a build-your-own meal plan is the practical step

If you have a history of eating disorders, GLP-1 treatment requires close monitoring by a provider who understands both the medication and the eating disorder dynamics